Eastern Cooperative Oncology Group

Eastern Cooperative Oncology Group logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Private, Subsidiary
Established
2012-01-01
Employees
51
Market Cap
-
Website
https://ecog-acrin.org

Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

Phase 3
Completed
Conditions
First Posted Date
2004-02-16
Last Posted Date
2023-06-22
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
744
Registration Number
NCT00002868
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

Royal Infirmary, Glasgow, Scotland, United Kingdom

๐Ÿ‡บ๐Ÿ‡ธ

Hackensack University Medical Center, Hackensack, New Jersey, United States

๐Ÿ‡บ๐Ÿ‡ธ

Riverview Medical Center - Booker Cancer Center, Red Bank, New Jersey, United States

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

Phase 2
Completed
Conditions
First Posted Date
2004-02-12
Last Posted Date
2013-06-24
Lead Sponsor
Eastern Cooperative Oncology Group
Registration Number
NCT00006786
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

Veterans Affairs Medical Center - Cleveland, Cleveland, Ohio, United States

๐Ÿ‡บ๐Ÿ‡ธ

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

and more 74 locations

Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer

Phase 2
Completed
Conditions
First Posted Date
2004-02-11
Last Posted Date
2023-06-18
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
22
Registration Number
NCT00077129
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Baptist Cancer Institute - Jacksonville, Jacksonville, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Saint Anthony Memorial Health Centers, Michigan City, Indiana, United States

๐Ÿ‡บ๐Ÿ‡ธ

Midwest Cancer Research Group, Incorporated, Skokie, Illinois, United States

and more 32 locations

Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma

Phase 3
Completed
Conditions
Interventions
First Posted Date
2004-01-14
Last Posted Date
2024-02-01
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
545
Registration Number
NCT00075946
Locations
๐Ÿ‡บ๐Ÿ‡ธ

CCOP - Columbus, Columbus, Ohio, United States

๐Ÿ‡บ๐Ÿ‡ธ

Siouxland Hematology-Oncology Associates, LLP, Sioux City, Iowa, United States

๐Ÿ‡บ๐Ÿ‡ธ

CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States

and more 475 locations

Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL

First Posted Date
2003-12-11
Last Posted Date
2023-06-29
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
102
Registration Number
NCT00074282
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Cancer Center of Kansas-Independence, Independence, Kansas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Marshfield Clinic at Saint Michael's Hospital, Stevens Point, Wisconsin, United States

๐Ÿ‡บ๐Ÿ‡ธ

Case Comprehensive Cancer Center, Cleveland, Ohio, United States

and more 140 locations

Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

Phase 2
Completed
Conditions
First Posted Date
2003-12-02
Last Posted Date
2023-06-22
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
38
Registration Number
NCT00003388
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Albert Einstein Comprehensive Cancer Center, Bronx, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Veterans Affairs Medical Center - Palo Alto, Palo Alto, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Raritan Bay Medical Center, Perth Amboy, New Jersey, United States

and more 2 locations

Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma

First Posted Date
2003-11-06
Last Posted Date
2023-06-28
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
175
Registration Number
NCT00071981
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Saint Joseph's Hospital, Marshfield, Wisconsin, United States

๐Ÿ‡บ๐Ÿ‡ธ

Bronson Methodist Hospital, Kalamazoo, Michigan, United States

๐Ÿ‡บ๐Ÿ‡ธ

Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest, Allentown, Pennsylvania, United States

and more 62 locations

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 2
Completed
Conditions
First Posted Date
2003-11-05
Last Posted Date
2013-06-21
Lead Sponsor
Eastern Cooperative Oncology Group
Registration Number
NCT00006008
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Veterans Affairs Medical Center - Lakeside Chicago, Chicago, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

New England Medical Center Hospital, Boston, Massachusetts, United States

and more 68 locations

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Phase 2
Completed
Conditions
First Posted Date
2003-11-05
Last Posted Date
2023-06-22
Lead Sponsor
Eastern Cooperative Oncology Group
Registration Number
NCT00005962
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

Hahnemann University Hospital, Philadelphia, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

CCOP - Columbus, Columbus, Ohio, United States

and more 62 locations

Methylphenidate in Treating Patients With Melanoma

First Posted Date
2003-10-28
Last Posted Date
2023-06-18
Lead Sponsor
Eastern Cooperative Oncology Group
Target Recruit Count
200
Registration Number
NCT00003266
Locations
๐Ÿ‡บ๐Ÿ‡ธ

CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

CCOP - Geisinger Clinic and Medical Center, Danville, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States

and more 56 locations
ยฉ Copyright 2024. All Rights Reserved by MedPath